o decompensated cirrhosis as primary diagnosis, irrespective of liver disease etiology (subset 1).

OR

other chronic end-stage liver diseases requiring LT, to be listed under a MELD-based allocation system (examples: primary biliary cholangitis, primary sclerosing cholangitis etc…) (subset 2).

OR

HCC* as primary diagnosis, whatever the etiology of the underlying liver disease.

with or without underlying cirrhosis (subset 3).

▪ HCC diagnosed on Barcelona/EASL criteria or histologically proven.

▪ HCC meeting or not Milan criteria, as per center practice.

• Patients registered on national waiting lists under the MELD offering schemes, regardless of extra MELD points and MELD exceptions are affected or not.

• Patient (or trusted person, family member or close relation, if the patient is unable to be informed) who has been informed and did not express opposition to data collection

*Of note, enrolment of patients with T1 tumors (1 single tumor < 2 cm diameter) not amenable to loco-regional therapies because of decompensation, and prioritized under the MELD system, will be allowed in Subset 1.